Adaptimmune Therapeutics PLC Annual Operating Margin in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Operating Margin history and growth rate from 2016 to 2024.
  • Adaptimmune Therapeutics PLC Operating Margin for the quarter ending December 31, 2024 was -38.6 %, a 83.3% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2024 was -38.6 %, a 83.3% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2023 was -232 %, a 61.6% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Operating Margin for 2022 was -604 %, a 77.1% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -38.6 +193 +83.3% Jan 1, 2024 Dec 31, 2024
2023 -232 +372 +61.6% Jan 1, 2023 Dec 31, 2023
2022 -604 +2.03K +77.1% Jan 1, 2022 Dec 31, 2022
2021 -2.64K +732 +21.7% Jan 1, 2021 Dec 31, 2021
2020 -3.37K +9.09K +72.9% Jan 1, 2020 Dec 31, 2020
2019 -12.5K -12.3K -8900% Jan 1, 2019 Dec 31, 2019
2018 -138 +74.8 +35.1% Jan 1, 2018 Dec 31, 2018
2017 -213 +300 +58.4% Jan 1, 2017 Dec 31, 2017
2016 -513 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.